Asabys Partners

Nuage Therapeutics, the spin-off from IRB Barcelona and ICREA, is launched with the support of Asabys

Nuage Therapeutics has announced the closing of a financing round by Sabadell Asabys, the investment vehicle managed by Asabys Partners. With this injection of capital, the spin-off will start its work discovering drugs aimed at therapeutic targets currently considered undruggable. The company was created by IRB Barcelona, ICREA, and the researchers Xavier Salvatella and Mateusz […]